These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 11888358)

  • 1. Human recombinant erythropoietin in the prevention and treatment of anemia of prematurity.
    Ohls RK
    Paediatr Drugs; 2002; 4(2):111-21. PubMed ID: 11888358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of erythropoietin in neonates.
    Ohls RK
    Clin Perinatol; 2000 Sep; 27(3):681-96. PubMed ID: 10986635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin to prevent and treat the anemia of prematurity.
    Ohls RK
    Curr Opin Pediatr; 1999 Apr; 11(2):108-14. PubMed ID: 10202619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant erythropoietin for prevention of anemia in preterm infants.
    Obladen M; Maier RF
    J Perinat Med; 1995; 23(1-2):119-26. PubMed ID: 7658311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of recombinant erythropoietin in treatment of the anemia of prematurity.
    Halpérin DS
    Am J Pediatr Hematol Oncol; 1991; 13(3):351-63. PubMed ID: 1793163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential for treatment of anemia of prematurity with recombinant human erythropoietin.
    Phibbs RH
    Curr Opin Pediatr; 1995 Apr; 7(2):140-5. PubMed ID: 7787927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human erythropoietin therapy in low-birthweight preterm infants: a prospective controlled study.
    Arif B; Ferhan K
    Pediatr Int; 2005 Feb; 47(1):67-71. PubMed ID: 15693870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current controversies in the management of the anemia of prematurity.
    Bishara N; Ohls RK
    Semin Perinatol; 2009 Feb; 33(1):29-34. PubMed ID: 19167579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does early erythropoietin therapy decrease transfusions in anemia of prematurity?
    Atasay B; Günlemez A; Akar N; Arsan S
    Indian J Pediatr; 2002 May; 69(5):389-91. PubMed ID: 12061670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose pharmacokinetics of recombinant human erythropoietin in preterm infants after intravenous and subcutaneous administration.
    Brown MS; Jones MA; Ohls RK; Christensen RD
    J Pediatr; 1993 Apr; 122(4):655-7. PubMed ID: 8463922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of high versus low dose recombinant human erythropoietin versus blood transfusion in the management of anaemia of prematurity in a developing country.
    Avent M; Cory BJ; Galpin J; Ballot DE; Cooper PA; Sherman G; Davies VA
    J Trop Pediatr; 2002 Aug; 48(4):227-33. PubMed ID: 12200985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of early human recombinant erythropoietin therapy on the transfusion in healthy preterm infants.
    Khatami SF; Mamouri G; Torkaman M
    Indian J Pediatr; 2008 Dec; 75(12):1227-30. PubMed ID: 19057854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of short-term recombinant human erythropoietin therapy in the prevention of anemia of prematurity in very low birth weight neonates.
    Yasmeen BH; Chowdhury MA; Hoque MM; Hossain MM; Jahan R; Akhtar S
    Bangladesh Med Res Counc Bull; 2012 Dec; 38(3):119-23. PubMed ID: 23540189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
    Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
    Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum erythropoietin concentrations fail to increase after significant phlebotomy losses in ill preterm infants.
    Ohls RK; Harcum J; Li Y; Davila G; Christensen RD
    J Perinatol; 1997; 17(6):465-7. PubMed ID: 9447534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of transfusions in extremely low-birthweight infants in the erythropoietin era.
    Hosono S; Mugishima H; Shimada M; Minato M; Okada T; Takahashi S; Harada K
    Pediatr Int; 2006 Dec; 48(6):572-6. PubMed ID: 17168976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of blood sampling stewardship and erythropoietin administration in extremely low birth weight infants-a quality improvement non-controlled before-and-after retrospective study.
    Balasubramanian H; Atyalgade M; Garg B; Srinivasan L; Kabra NS; Khapekar S
    Eur J Pediatr; 2021 May; 180(5):1617-1626. PubMed ID: 33464366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anemia of prematurity: the prospects for avoiding blood transfusions by treatment with recombinant human erythropoietin.
    Dallman PR
    Adv Pediatr; 1993; 40():385-403. PubMed ID: 8249712
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial.
    Donato H; Vain N; Rendo P; Vivas N; Prudent L; Larguía M; Digregorio J; Vecchiarelli C; Valverde R; García C; Subotovsky P; Solana C; Gorenstein A
    Pediatrics; 2000 May; 105(5):1066-72. PubMed ID: 10790464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recombinant erythropoietin and early preterm neonatal anemia].
    Piasetskaia NM
    Lik Sprava; 1999 Jun; (4):47-51. PubMed ID: 10476641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.